March 13, 2020 / 1:07 PM / a month ago

BRIEF-Algernon Files Pre-Ind Meeting Request For Ifenprodil Coronavirus Trial With U.S. FDA

March 13 (Reuters) - Algernon Pharmaceuticals Inc:

* ALGERNON ANNOUNCES FILING OF U.S. FDA PRE-IND MEETING REQUEST FOR IFENPRODIL CORONAVIRUS TRIAL, EXPANDED ACCESS, AND EMERGENCY USE

* ALGERNON PHARMACEUTICALS INC - REQUEST FOR A PRE-IND MEETING WAS ACCOMPANIED BY COMPLETE PRE-IND BRIEFING DOCUMENT

* ALGERNON PHARMACEUTICALS - FILING INCLUDES CLARIFICATION OF EXPANDED ACCESS PATHWAY FOR IFENPRODIL Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below